Product
Timolol Maleate
6 clinical trials
6 indications
Indication
Primary Open Angle GlaucomaIndication
ocular hypertensionIndication
GlaucomaIndication
Infantile HemangiomaIndication
HemangiomaIndication
Hereditary Hemorrhagic TelangiectasiaClinical trial
A Randomized Active-controlled Multi-site Double-masked Study to Evaluate the Safety and Tolerability of 3 Concentrations of QLS-101 Versus Timolol Maleate Preservative Free (PF) 0.5% Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2022-02-17
Clinical trial
A Phase III, Randomized, Double-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 StudyStatus: Completed, Estimated PCD: 2019-10-23
Clinical trial
A Phase IIb, Randomized, Double-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2021-12-07
Clinical trial
Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)Status: Completed, Estimated PCD: 2020-10-20
Clinical trial
Treatment of Cutaneous Hemangioma of Infancy With Topical 0.5% Timolol Maleate Eye Drop Compared With Placebo in Pediatric Patients, Siriraj HospitalStatus: Completed, Estimated PCD: 2023-03-01
Clinical trial
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of ConceptStatus: Completed, Estimated PCD: 2019-08-30